StonvexLoading…
StonvexStonvexStonvexCore line items from PMNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 |
|---|---|---|---|
Revenue | $21.50M | $24.44M | $23.44M |
Operating Income | $-13.80M | $-7.67M | $-8.63M |
Net Income | $-15.94M | $-8.72M | $-10.30M |
EPS (Diluted) | $-0.99 | $-1.34 | $-2.16 |
Total Assets | $13.34M | $12.61M | $9.82M |
Total Liabilities | $11.48M | $4.85M | $13.96M |
Cash & Equivalents | $6.16M | $7.91M | $4.71M |
Free Cash Flow OCF − CapEx | $-10.16M | $-4.66M | $-3.76M |
Shares Outstanding | 19.29M | 15.65M | 4.82M |